← back to search

Oliver Mortusewicz

Science for Life Laboratory · SE
Area of research
Molecular Biology · Oncology
Research interest
Research interests include DNA Repair Mechanisms, PARP inhibition in cancer therapy, DNA and Nucleic Acid Chemistry, and Cancer-related Molecular Pathways.
h-index
30
citations
3,276
works
88
NIH funding
primary concept
email

Recent publications

Virtual fragment screening for DNA repair inhibitors in vast chemical space
Nature Communications 2025cited by 13position: middledoi
Formate overflow drives toxic folate trapping in MTHFD1 inhibited cancer cells
Nature Metabolism 2023cited by 50position: middledoi
Small-molecule activation of OGG1 increases oxidative DNA damage repair by gaining a new function
Science 2022cited by 74position: middledoi
Targeting OGG1 arrests cancer cell proliferation by inducing replication stress
Nucleic Acids Research 2020cited by 58position: middledoi
Small-molecule inhibitor of OGG1 suppresses proinflammatory gene expression and inflammation
Science 2018cited by 229position: middledoi
The spliceosome U2 snRNP factors promote genome stability through distinct mechanisms; transcription of repair factors and R-loop processing
Oncogenesis 2016cited by 57position: lastdoi
Cancer-Specific Synthetic Lethality between ATR and CHK1 Kinase Activities
Cell Reports 2015cited by 146position: middledoi
Timeless Interacts with PARP-1 to Promote Homologous Recombination Repair
Molecular Cell 2015cited by 131position: middledoi
DNA-PKcs and PARP1 Bind to Unresected Stalled DNA Replication Forks Where They Recruit XRCC1 to Mediate Repair
Cancer Research 2015cited by 85position: middledoi
Increased replication initiation and conflicts with transcription underlie Cyclin E-induced replication stress
Oncogene 2012cited by 290position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Thomas Helleday · Science for Life Laboratory6 papers (2012–2025)Patrick Herr · Immodulon Therapeutics (United Kingdom)2 papers (2015–2016)Kumar Sanjiv · Science for Life Laboratory2 papers (2015–2016)Ulrika Warpman Berglund · Orexo (Sweden)2 papers (2015–2025)Martin Scobie · Orexo (Sweden)2 papers (2015–2025) · 1 papers (2025–2025)Zhengqiang Bao · Zhejiang University1 papers (2015–2015)John R. Pollard · e-Therapeutics (United Kingdom)1 papers (2015–2015)Ingrid Almlöf · Karolinska University Hospital1 papers (2025–2025)Elisée Wiita · Karolinska University Hospital1 papers (2025–2025)Zhihui Chen · Guangxi University1 papers (2015–2015)Duc Duy Vo · Science for Life Laboratory1 papers (2025–2025)Liuzhen Meng · Science for Life Laboratory1 papers (2025–2025)Sylvain A. Jacques · Université de Strasbourg1 papers (2015–2015)Niklas Schultz · Karolinska Institutet1 papers (2015–2015) · 1 papers (2015–2015) · 1 papers (2025–2025)Raoul Kuiper · Norwegian Veterinary Institute1 papers (2015–2015)Flavio Ballante · Science for Life Laboratory1 papers (2025–2025)José Manuel Calderón‐Montaño · Universidad de Sevilla1 papers (2015–2015)